UK Life Sciences Company Directory
Search and compare 1,500+ UK life sciences companies across biotech, biopharma, CROs, CDMOs, diagnostics, research tools and other specialist sectors by category, location and capability.
Arcadia Pharma
MHRA-licensed manufacturer of unlicensed medicines and Specials
Arcadia Pharmaceuticals is a licensed contract manufacturer of unlicensed medicines, supplying Specials and Special Obtain products to NHS and pharmacy customers across the UK. Operating from GMP cleanroom facilities in Swansea, the company manufactures a range of dosage forms including oral liquids, topical…
IsomAb
Isoform-specific antibody therapeutics for vascular disease
IsomAb is a biotechnology company developing isoform-specific antibody therapeutics for serious vascular diseases. Its lead programme, ISM-001, targets VEGF-A165b, an anti-angiogenic splice isoform implicated in peripheral arterial disease and chronic limb-threatening ischaemia. The company uses a…
NextMove Software
Cheminformatics software for chemical search and drug discovery
NextMove Software is a scientific software company developing cheminformatics tools for pharmaceutical, chemical and biotechnology research. Its applications search molecular structures, extract chemical names and reactions from patents, and analyse electronic laboratory notebook records. The company also supplies…
Edinburgh Molecular Imaging
Molecular imaging and targeted cancer therapy agents
Edinburgh Molecular Imaging is a biopharmaceutical company developing molecular imaging and targeted therapeutic agents for cancer and other diseases. Its research includes fluorescent peptide probes for image-guided surgery and radiolabelled compounds directed at c-Met, a receptor expressed in several tumour types.…
Grove Nanomaterials
Solvent-free gold nanoparticles for lateral flow and IVD diagnostics
Grove Nanomaterials is a Welsh nanotechnology company developing a sustainable, solvent-free manufacturing process for gold nanoparticles used in lateral flow assays and in-vitro diagnostics. Based on patented nanoparticle beam deposition technology developed at Swansea University, the process eliminates the chemical…
IVF 2.0
AI software for embryo and sperm selection in assisted reproductive technology
IVF 2.0 is a software company developing artificial intelligence tools for use in in vitro fertilisation laboratories. Its products apply computer vision and deep learning to microscopy imagery to provide quantitative assessments of embryo and sperm quality, supporting embryologists in selection decisions that are…
Enterprise Therapeutics
Small molecule therapies for cystic fibrosis and COPD
Enterprise Therapeutics is a clinical-stage biopharmaceutical company developing novel muco-regulatory therapies for respiratory diseases. Its lead programme ETD001 is a first-in-class inhaled ENaC blocker designed to hydrate airway mucus and improve mucociliary clearance, currently in a Phase 2a trial in cystic…
Malvern Panalytical
Precision instruments for chemical, physical and structural materials analysis
Malvern Panalytical manufactures precision analytical instruments, software and services that measure the chemical, physical and structural properties of materials. The company specialises in particle characterisation, X ray diffraction, X ray fluorescence, rheology and molecular interaction analysis, supporting…
Global Access Diagnostics
End-to-end lateral flow immunoassay development and manufacturing
Global Access Diagnostics (GADx) is a contract developer and manufacturer of rapid lateral flow immunoassay tests for human, veterinary, and agricultural applications. Operating as a social enterprise, GADx provides end-to-end diagnostic development services from assay design and antibody development through to…
CanSense
Raman spectroscopy blood test for early cancer detection
CanSense is a Welsh biotechnology company developing a non-invasive blood test for the early detection of bowel and other cancers. The platform combines Raman laser spectroscopy with artificial intelligence to identify cancer-associated metabolic signatures in blood, delivering results within 48 hours without…
Cheshire Scientific
Microbiological and chemical testing for water, pharmaceutical and healthcare samples
Cheshire Scientific is a microbiological and chemical analysis testing laboratory providing accredited sample testing for water, feed, food, pharmaceutical, cosmetic and environmental samples. Services include testing for Legionella, coliform bacteria and Pseudomonas, serving clients across healthcare, education,…
Nikon BioImaging Lab
Contract microscopy imaging and analysis services for life sciences
Nikon BioImaging Lab is a contract research organisation based at the Babraham Research Campus in Cambridge, providing microscope-based imaging and analysis services to biotech and pharmaceutical clients. Services span sample imaging, high-content acquisition, AI-powered data analysis using Nikon's NIS Elements…
Silence Therapeutics
siRNA therapeutics targeting liver-expressed disease genes
Silence Therapeutics is a clinical-stage biotechnology company developing siRNA therapeutics using its proprietary platform. The platform enables precise silencing of disease-associated genes expressed in the liver, without permanently altering DNA. Its pipeline addresses cardiovascular disease, haematological…
The Babraham Institute
Research institute studying the biology of ageing and lifelong health
The Babraham Institute is a life sciences research institute studying the biological mechanisms behind ageing, development and lifelong health. Its research spans epigenetics, immunology and cellular signalling, investigating how gene activity, the immune system and intercellular communication shape health outcomes…
Gylden Pharma
Synthetic T cell-priming vaccines and immunotherapies for infectious disease
Gylden Pharma is a clinical-stage biotechnology company developing 100% synthetic T cell-priming vaccines and immunotherapies. Its nanoparticle platform delivers synthetic peptides that stimulate cellular immune responses against intracellular pathogens, providing strain-agnostic protection without cold-chain…
Focalis Bio
AAV gene therapy targeting the seizure focus in refractory epilepsy
Focalis Bio is a biotechnology company developing gene therapies for focal refractory epilepsy, a condition in which seizures arise from a specific brain region and do not respond to antiseizure medicines. Its lead programme, EPY201, is an AAV9-based gene therapy delivered locally via catheter directly to the…
CamGene Therapeutics
LNP-mRNA growth factor therapy to restore hearing loss
CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause. Its lead approach uses an LNP-mRNA growth factor therapeutic designed to regenerate cochlear nerve cells and reduce inflammation, aiming to restore…
Tenpoint Therapeutics
Approved presbyopia eye drops and investigational retinal therapies
Tenpoint Therapeutics is an ophthalmic biopharmaceutical company developing medicines and regenerative cell therapies for age-related vision disorders. Its dual-agent carbachol/brimonidine eye drops received US FDA approval for presbyopia in January 2026 and became commercially available in March. A UK regulatory…
Edinburgh Technopole
Life sciences and technology campus on the Bush Estate, Midlothian
Edinburgh Technopole is a life sciences and technology science park set within 126 acres of parkland on the Bush Estate, 8 miles south of Edinburgh. Operated by Pioneer Group in partnership with the University of Edinburgh, the campus provides flexible laboratory, office, and small-scale manufacturing space to…
CoSyne Therapeutics
AI drug discovery platform targeting neurological diseases
CoSyne Therapeutics is a drug discovery company applying AI and computational methods to identify and develop therapeutics for neurological diseases. The company describes its approach as polymathic AI, integrating models across biology, chemistry, and genomics to generate and prioritise drug targets. CoSyne operates…